Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/12/2012CN102666536A Novel naphthyridine derivatives and the use thereof as kinase inhibitors
09/12/2012CN102666535A Imidazole derivatives as aldosterone synthase inhibitors
09/12/2012CN102666531A Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/12/2012CN102666530A Imatinib dichloroacetate and anti-cancer agent comprising the same
09/12/2012CN102666529A Triazine-aryl-bis-indoles and process for preparation thereof
09/12/2012CN102666528A Crystalline CDC7 inhibitor salts
09/12/2012CN102666526A Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
09/12/2012CN102666525A Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof
09/12/2012CN102666523A Macrocyclic lactone derivatives for the treatment of cancer
09/12/2012CN102666511A Crystalline methylthioninium chloride hydrates
09/12/2012CN102666510A Process
09/12/2012CN102666509A Thiazole derivatives for treating diseases such as cancer
09/12/2012CN102666508A Phenyloxadiazole derivatives as pgds inhibitors
09/12/2012CN102666507A Oxazine derivatives and their use in the treatment of neurological disorders
09/12/2012CN102666506A Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1
09/12/2012CN102666504A Compounds as lysophosphatidic acid receptor antagonists
09/12/2012CN102666500A Seven-membered ring compound and pharmaceutical use therefor
09/12/2012CN102666499A Process for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative
09/12/2012CN102666498A RAF inhibitor compounds and methods of use thereof
09/12/2012CN102666495A Potassium channel modulators
09/12/2012CN102666493A Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
09/12/2012CN102666491A Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
09/12/2012CN102666490A Aminopyridine compound
09/12/2012CN102666489A Sphingosine kinase inhibitors
09/12/2012CN102666488A Piperazines as antimalarial agents
09/12/2012CN102666485A Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
09/12/2012CN102666484A Alpha adrenergic receptor modulators
09/12/2012CN102666480A Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct
09/12/2012CN102666476A Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease
09/12/2012CN102665762A Film-like pharmaceutical dosage forms
09/12/2012CN102665756A Method of treatment of philadelphia chromosome positive leukaemia
09/12/2012CN102665750A Nutritional composition beneficial to small intestine
09/12/2012CN102665738A Prophylactic composition for influenza infection
09/12/2012CN102665734A Surface coatings for skin
09/12/2012CN102665733A Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders
09/12/2012CN102665732A Pharmaceutical composition for the treatment of bladder disorders
09/12/2012CN102665731A Compositions and methods for modulation of SMN2 splicing in a subject
09/12/2012CN102665730A Ophthalmic formulation and method of manufacture thereof
09/12/2012CN102665729A Methods of treating viral associated diseases
09/12/2012CN102665728A Medicinal carbohydrates for treatment of respiratory conditions
09/12/2012CN102665727A Anti-cancer agent
09/12/2012CN102665726A 抗癌剂 Anticancer agent
09/12/2012CN102665725A Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
09/12/2012CN102665724A Composition containing protopanaxatriol and protopanaxadiol
09/12/2012CN102665723A Use of an oleo gel containing triterpene for healing wounds
09/12/2012CN102665722A Orally administered corticosteroid compositions
09/12/2012CN102665721A Use of polysaccharides for treating stress and anxiety
09/12/2012CN102665720A Combination
09/12/2012CN102665719A Combination
09/12/2012CN102665718A Heterocyclic compounds useful as pdk1 inhibitors
09/12/2012CN102665717A Learning motivation improvers
09/12/2012CN102665716A Methods and pharmaceutical compositions for treating Down syndrome
09/12/2012CN102665715A Compositions for treatment of cystic fibrosis and other chronic diseases
09/12/2012CN102665714A Treatment of atrial fibriallation
09/12/2012CN102665713A Method of treating atrial fibrillation
09/12/2012CN102665712A Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphtalenyl) ester
09/12/2012CN102665711A Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents
09/12/2012CN102665710A Agent for inhibiting decrease of visceral fat in patient with Parkinson's disease
09/12/2012CN102665709A Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof
09/12/2012CN102665708A A combination for the treatment of osteoarthritis
09/12/2012CN102665707A N-acetyl-l-cysteine for the treatment of endometriosis
09/12/2012CN102665706A Antioxidant composition
09/12/2012CN102665705A New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
09/12/2012CN102665704A Compositions including pyruvate for companion animals and methods of use thereof
09/12/2012CN102665703A Inhibitors of CXCR1/2 as adjuvants in the transplant of pancreatic islets
09/12/2012CN102665702A Hydroxytyrosol compounds
09/12/2012CN102665701A Ceramide and collagen synthesis promoter and collagen saccharification inhibitor
09/12/2012CN102665700A Methods and compositions for treating solid tumors and other malignancies
09/12/2012CN102665699A Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
09/12/2012CN102665698A Combination composition useful for treating cardiovascular diseases
09/12/2012CN102665694A Abuse-resistant formulations
09/12/2012CN102665693A Solid dispersion of rifaximin
09/12/2012CN102665683A Emergency contraceptive
09/12/2012CN102665681A Composition of dexibuprofen transdermal hydrogel
09/12/2012CN102665680A Aerosol formulation for copd
09/12/2012CN102665679A Combination therapy for copd
09/12/2012CN102665678A Combination therapy for copd
09/12/2012CN102665677A Carrageenan-containing aqueous antimicrobial compositions
09/12/2012CN102665675A Improved medicinal aerosol formulations
09/12/2012CN102665421A Method of treating osteoporosis
09/12/2012CN102665418A Combination
09/12/2012CN102665412A Compositions and methods for inducing or enhancing connective tissue repair
09/12/2012CN102665410A Contact lens disinfecting solutions
09/12/2012CN102659958A Dandelion polysaccharide extract and preparation method and application thereof
09/12/2012CN102659904A Preparation method for hederagenin and salts thereof
09/12/2012CN102659894A Hexose ester, synthetic method thereof and use thereof
09/12/2012CN102659889A Preparation of 23, 24-dihydro-epi-iso-cucurbitacin D and use in antitumor drug thereof
09/12/2012CN102659880A Erythromycin ethylsuccinate crystalline hydrate and preparation method and application thereof
09/12/2012CN102659876A Flavonoid glycoside extracted from cardamine tangutorum and preparation method thereof
09/12/2012CN102659844A Cr (III) chelate, and preparation method and application thereof
09/12/2012CN102659843A D, L-guanosine nucleoside analog monophosphate, and preparation method and application thereof
09/12/2012CN102659840A Imidazole diphosphonie acid compound and pharmaceutically-acceptable salt and medicinal application thereof
09/12/2012CN102659823A Amino acid copper complex with effects of preventing alopecia, growing hair growth and protecting skin, preparation method and application
09/12/2012CN102659820A Cefmetazole sodium crystal compound, preparation method thereof and sterile powder for injection containing cefmetazole sodium crystal compound
09/12/2012CN102659818A Hydrochloric acid cefotiam crystalline compound, preparation method thereof and medicine combination containing compound
09/12/2012CN102659813A 2-((2-(3-aminopiperidine-1)-4-oxythiophene (3, 2-d) pyrimidine-3(4H)-methyl) polymorphic benzonitrile, and preparation method and pharmacological applications thereof
09/12/2012CN102659803A Sesterterpene compound and preparation method and application thereof
09/12/2012CN102659802A Preparation method of coumarin lignan compounds and application of coumarin lignan compounds in resisting marine fouling
09/12/2012CN102659800A Hypoxia-activated antitumor compounds and application thereof
09/12/2012CN102659793A Phthalocyanine silicon modified by amino ethyl groups and phenoxy groups as well as preparation method and application thereof
1 ... 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 ... 7860